NxStage Medical (NSDQ:NXTM) shares jumped nearly 8% today after the medical device company reported Wall-Street-beating results for the 4th quarter and 2012.
2012
Mako gets a Wall Street boost as sales soar, losses narrow in 2012
Surgical devices maker Mako Surgical (NSDQ:MAKO), maker of the Rio robotic surgery system, posted impressive boosts to its sales during the 4th quarter and full year of 2012.
Philips swings to 2012 profits on strong healthcare demand
HeartWare’s Q4, 2012 sales surge
Sales of its implantable heart pump surged during the 4th quarter and 2012 for HeartWare International (NSDQ:HTWR) after the medical device company won FDA approval for its flagship left ventricular assist device late last year.
NuVasive gains on narrower Q4 losses, revenue beat
Shares of NuVasive Inc. (NSDQ:NUVA) closed up nearly 7% yesterday after the medical device company reported narrowing its 4th-quarter losses by some 73% and beat Wall Street’s sales expectations for the quarter.
The San Diego-based spinal implant maker posted losses of $2.7 million, or 6¢ per share, on sales of $165.8 million for the 3 months ended Dec. 31, 2012, for sales growth of 10.4%.
Medtronic’s Irish profits rise 119% | Wall Street Beat
Wright Medical gains on swing to 2012 black
Shares of Wright Medical (NSDQ:WMGI) are up about 6% since the medical device company reported a return to annual profitability last week on strong 4th-quarter results.
Volcano shares dive on lowered guidance
Orthofix Q4 earnings boom but sales lag on challenges overseas
Medtronic’s Q3 sales, earnings rise
Medtronic (NYSE:MDT) posted profit and sales gains during its fiscal 3rd quarter this morning, eating Wall Street analysts’ earnings expectations along the way.
The Fridley, Minn.-based company, which is the world’s largest pure-play medical device company, said profits were up 5.7% on sales growth of 2.8% for the 3 months ended Jan. 25.
ArthroCare shares flat on DoJ overhang despite swings to Q4, 2012 black
Investors stayed on the sidelines last week on shares of ArthroCare (NSDQ:ARTC), despite its return to black ink for both the 4th quarter and full year, as they awaited more information on pending U.S. Justice Dept. investigations.